Assessment of Potential Interactions Between Cocaine and Tolcapone - 1
This trial is unknown status.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Start date||July 2001|
|End date||March 2002|
|Trial size||16 participants|
|Trial identifier||NCT00033059, NCT00024765, NIDA-CTO-0003-1|
The purpose of this study is to assess the potential interactions between intravenous (IV) cocaine and tolcapone.
Male or female participants from 18 years up to 45 years old.
|Official title||Assessment of Potential Interactions Between Intravenous Cocaine and Tolcapone|
|Principal investigator||Thomas Newton, M.D.|
|Description||Double-blind, inpatient study by screening responses to cocaine infusions of 20 and 40 mg i.v. subjects into 1 of 2 treatment groups to assess potential interactions between i.v. cocaine infusion and treatment with tolcapone.|
Call for more information